Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_assertion evidence source_evidence_literature NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_assertion SIO_000772 19642140 NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_assertion wasDerivedFrom befree-20150227 NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_assertion wasGeneratedBy ECO_0000203 NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP289665.RApZCynQrg_UzN8Yt8Mk7qEleV0PIiaP5p9y1gYe-tH6A130_provenance.